Dietary Supplement and Medication Use in Professional and Pre-Professional Dancers: Widespread Use but Limited Evidence of Benefit—A Systematic Review

Why It Matters

The high prevalence of supplement and medication use, combined with limited efficacy data, poses health and performance risks for dancers and highlights a critical gap in sport‑nutrition guidance for this elite population.

Key Takeaways

• Supplement use among dancers ranges 11%‑57%, with multivitamins most common.
• Up to 90% of dancers regularly take analgesics or NSAIDs.
• Vitamin D supplementation improves strength, jump height, and cuts injury rates.
• Whey protein and creatine boost lean mass but show limited performance gains.

Pulse Analysis

Dancers operate at the intersection of art and sport, enduring training volumes that often exceed six hours daily and exposing themselves to repetitive loading, extreme ranges of motion, and a high incidence of overuse injuries. This unique physiological stress profile drives many performers to seek nutritional and pharmacological aids, mirroring trends seen in elite athletics. However, unlike more studied sports, dance lacks a robust evidence base, leaving practitioners to rely on anecdote and commercial marketing when recommending supplements or pain‑relief medications.

The review highlights that while 11%‑57% of dancers consume dietary supplements—most frequently multivitamins, vitamin C, caffeine and isotonic beverages—up to 90% also use analgesics or NSAIDs to manage musculoskeletal pain. Vitamin D emerged as the sole supplement with consistent, measurable benefits, enhancing isometric strength, vertical jump height, and lowering injury rates. In contrast, whey protein and creatine produced modest gains in lean mass but failed to translate into superior performance metrics, suggesting that supplementation alone cannot compensate for the specific training demands of dance. The pervasive use of NSAIDs raises concerns about symptom masking, delayed injury reporting, and potential interference with tissue remodeling.

Given the fragmented and low‑quality nature of existing research, the dance community faces an urgent need for rigorously designed, dancer‑specific randomized controlled trials. Such studies should standardize dosing protocols, integrate sport‑specific performance tests, and monitor long‑term health outcomes. Until then, clinicians and coaches should prioritize comprehensive nutritional assessments, address common deficiencies like vitamin D and iron, and exercise caution with routine NSAID use. Establishing evidence‑based guidelines will not only safeguard dancer health but also create market opportunities for scientifically validated nutraceuticals tailored to the performing arts.